Friday, January 16, 2026 | 01:46 PM ISTहिंदी में पढें
Page 3 - Biocon Ltd News
Deepali Naair to lead Brand & Corporate Communications at Biocon Biologics
Naair will lead Biocon Biologics' global brand and corporate communications strategy as part of its executive team, reporting directly to CEO and MD Shreehas Tambe
 "Deepali Naair to lead Brand & Corporate Communications at Biocon Biologics")
Updated On : 23 Jul 2025 | 6:00 PM IST
Glenmark, Laurus: 4 pharma stocks gain up to 79% in 5 months; time to exit?
The daily RSI, a key momentum indicator, shows that these 4 pharma stocks namely - Gland Pharma, Glenmark, Biocon and Laurus Labs are trading in the overbought territory; here's what to expect next.
 "Glenmark, Laurus: 4 pharma stocks gain up to 79% in 5 months; time to exit?")
Updated On : 22 Jul 2025 | 11:42 AM IST
Biocon Biologics expands diabetes portfolio with FDA approval for Kirsty
Interchangeable biosimilar to NovoLog in the US and will be available in prefilled pens and vials
Updated On : 16 Jul 2025 | 1:39 PM IST
Should you buy Biocon shares as USFDA gives approval to diabetes drug?
At 09:30 AM, Biocon shares were trading at ₹398.15, up by 1.97 per cent on the National Stock Exchange.
 "Should you buy Biocon shares as USFDA gives approval to diabetes drug?")
Updated On : 16 Jul 2025 | 10:13 AM IST